Literature DB >> 11751794

IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK.

Luke Tysall, Mark W Stockdale, Paul R Chadwick, Marie-France I Palepou, Kevin J Towner, David M Livermore, Neil Woodford.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11751794     DOI： 10.1093/jac/49.1.217

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.

Authors:  F Lopez-Otsoa; L Gallego; K J Towner; L Tysall; N Woodford; D M Livermore
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.

Authors:  Catherine Neuwirth; Eliane Siebor; Frederic Robin; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

Review 3.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

4.  Biochemical characterization of IMP-30, a metallo-β-lactamase with enhanced activity toward ceftazidime.

Authors:  Kevin M Pegg; Eleanor M Liu; Alecander E Lacuran; Peter Oelschlaeger
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

5.  Identification and characterization of an unusual metallo-β-lactamase from Serratia proteamaculans.

Authors:  Peter Vella; Manfredi Miraula; Emer Phelan; Eleanor W W Leung; Fernanda Ely; David L Ollis; Ross P McGeary; Gerhard Schenk; Nataša Mitić
Journal:  J Biol Inorg Chem       Date:  2013-08-28       Impact factor: 3.358

6.  Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase.

Authors:  Laura Pagani; Céline Colinon; Roberta Migliavacca; Maria Labonia; Jean-Denis Docquier; Elisabetta Nucleo; Melissa Spalla; Michele Li Bergoli; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 7.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  IMP-12, a new plasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate.

Authors:  Jean-Denis Docquier; Maria Letizia Riccio; Claudia Mugnaioli; Francesco Luzzaro; Andrea Endimiani; Antonio Toniolo; Gianfranco Amicosante; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

9.  Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance.

Authors:  Raffaele Zarrilli; Margherita Crispino; Maria Bagattini; Elena Barretta; Anna Di Popolo; Maria Triassi; Paolo Villari
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  Biochemical characterization of the acquired metallo-beta-lactamase SPM-1 from Pseudomonas aeruginosa.

Authors:  Tanya A Murphy; Alan M Simm; Mark A Toleman; Ronald N Jones; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.